MR Imaging for Accurate Response Monitoring in Glioblastoma Multiforme During Bevacizumab Therapy

被引：0
|
作者：
Korn, A.
Braun, C.
Fenchel, M.
Ernemann, U.
Horger, M.
机构：
来源：
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN | 2012年 / 184卷 / 05期
关键词：
D O I：
10.1055/s-0031-1274843
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：397 / 401
页数：5
相关论文
共 50 条
  • [1] Prediction of Glioblastoma Multiforme Response to Bevacizumab Treatment Using Diffusion and Perfusion Imaging
    Abadi, Ehsan
    Soltanian-Zadeh, Hamid
    Scarpace, Lisa
    Mikkelsen, Tom
    [J]. 2015 22ND IRANIAN CONFERENCE ON BIOMEDICAL ENGINEERING (ICBME), 2015, : 314 - 318
  • [2] Proton MR Spectroscopy and Diffusion MR Imaging Monitoring to Predict Tumor Response to Interstitial Photodynamic Therapy for Glioblastoma
    Toussaint, Magali
    Pinel, Sophie
    Auger, Florent
    Durieux, Nicolas
    Thomassin, Magalie
    Thomas, Eloise
    Moussaron, Albert
    Meng, Dominique
    Plenat, Francois
    Amouroux, Marine
    Bastogne, Thierry
    Frochot, Celine
    Tillement, Olivier
    Lux, Francois
    Barberi-Heyob, Muriel
    [J]. THERANOSTICS, 2017, 7 (02): : 436 - 451
  • [3] Multimodal MR imaging findings of a congenital glioblastoma multiforme
    Fuldem Yildirim Donmez
    Hulya Aslan
    Gokcen Coban
    Ozlem Ozen
    Muhtesem Agildere
    [J]. Child's Nervous System, 2012, 28 : 1831 - 1833
  • [4] Multimodal MR imaging findings of a congenital glioblastoma multiforme
    Donmez, Fuldem Yildirim
    Aslan, Hulya
    Coban, Gokcen
    Ozen, Ozlem
    Agildere, Muhtesem
    [J]. CHILDS NERVOUS SYSTEM, 2012, 28 (11) : 1831 - 1833
  • [5] The Role of Kinase Signaling in Resistance to Bevacizumab Therapy for Glioblastoma Multiforme
    Ramezani, Sara
    Vousooghi, Nasim
    Joghataei, Mohammad Taghi
    Chabok, Shahrokh Yousefzadeh
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (06) : 345 - 354
  • [6] Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases
    Ali, Sheikh A.
    McHayleh, Wassim M.
    Ahmad, Asif
    Sehgal, Rajesh
    Braffet, Molly
    Rahman, Mohsin
    Bejjani, Ghassan
    Friedland, David M.
    [J]. JOURNAL OF NEUROSURGERY, 2008, 109 (02) : 268 - 272
  • [7] A prognostic model for clinical response to bevacizumab in recurrent glioblastoma multiforme
    Urup, Thomas
    Michaelsen, Signe Regner
    Holst, Camilla Bjornbak
    Toft, Anders
    Christensen, Ib Jarle
    Grunnet, Kirsten
    Kosteljanetz, Michael
    Broholm, Helle
    Lassen, Ulrik
    Poulsen, Hans Skovgaard
    [J]. CANCER RESEARCH, 2015, 75
  • [8] RESPONSE OF PROGRESSIVE PEDIATRIC BIFRONTAL GLIOBLASTOMA MULTIFORME TO A COMBINATION OF TARGETED THERAPY USING TEMSIROLIMUS AND BEVACIZUMAB
    Pearlman, Michael L.
    Sadighi, Zsila
    Bingham, Rachel
    Vats, Trib
    Khatua, Soumen
    [J]. NEURO-ONCOLOGY, 2011, 13 : 96 - 97
  • [9] Perfusion MR imaging and proton MR spectroscopic imaging in differentiating necrotizing cerebritis from glioblastoma multiforme
    Pivawer, Gabriel
    Law, Meng
    Zagzag, David
    [J]. MAGNETIC RESONANCE IMAGING, 2007, 25 (02) : 238 - 243
  • [10] Evaluation of early imaging response criteria in glioblastoma multiforme
    Gladwish, Adam
    Koh, Eng-Siew
    Hoisak, Jeremy
    Lockwood, Gina
    Millar, Barbara-Ann
    Mason, Warren
    Yu, Eugene
    Laperriere, Normand J.
    Menard, Cynthia
    [J]. RADIATION ONCOLOGY, 2011, 6
12345